Logo image of SCPX

SCORPIUS HOLDINGS INC (SCPX) Stock Fundamental Analysis

USA - NYSEARCA:SCPX - US42237K5083 - Common Stock

0.068 USD
-0.06 (-48.48%)
Last: 4/21/2025, 8:04:00 PM
Fundamental Rating

2

Overall SCPX gets a fundamental rating of 2 out of 10. We evaluated SCPX against 534 industry peers in the Biotechnology industry. SCPX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SCPX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SCPX has reported negative net income.
SCPX had a negative operating cash flow in the past year.
SCPX had negative earnings in each of the past 5 years.
In the past 5 years SCPX always reported negative operating cash flow.
SCPX Yearly Net Income VS EBIT VS OCF VS FCFSCPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

SCPX has a worse Return On Assets (-72.96%) than 66.49% of its industry peers.
Looking at the Return On Equity, with a value of -128.83%, SCPX is doing worse than 60.32% of the companies in the same industry.
Industry RankSector Rank
ROA -72.96%
ROE -128.83%
ROIC N/A
ROA(3y)-53.06%
ROA(5y)-51.43%
ROE(3y)-77.93%
ROE(5y)-80.68%
ROIC(3y)N/A
ROIC(5y)N/A
SCPX Yearly ROA, ROE, ROICSCPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -100 -200 -300 -400

1.3 Margins

SCPX's Gross Margin of 68.54% is amongst the best of the industry. SCPX outperforms 80.60% of its industry peers.
SCPX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCPX Yearly Profit, Operating, Gross MarginsSCPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

0

2. Health

2.1 Basic Checks

SCPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
SCPX has more shares outstanding than it did 1 year ago.
SCPX has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, SCPX has a worse debt to assets ratio.
SCPX Yearly Shares OutstandingSCPX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
SCPX Yearly Total Debt VS Total AssetsSCPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

SCPX has an Altman-Z score of -9.40. This is a bad value and indicates that SCPX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.40, SCPX is doing worse than 72.66% of the companies in the same industry.
A Debt/Equity ratio of 0.31 indicates that SCPX is not too dependend on debt financing.
SCPX has a worse Debt to Equity ratio (0.31) than 71.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -9.4
ROIC/WACCN/A
WACC4.43%
SCPX Yearly LT Debt VS Equity VS FCFSCPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

SCPX has a Current Ratio of 0.38. This is a bad value and indicates that SCPX is not financially healthy enough and could expect problems in meeting its short term obligations.
SCPX has a worse Current ratio (0.38) than 94.36% of its industry peers.
SCPX has a Quick Ratio of 0.38. This is a bad value and indicates that SCPX is not financially healthy enough and could expect problems in meeting its short term obligations.
SCPX's Quick ratio of 0.26 is on the low side compared to the rest of the industry. SCPX is outperformed by 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.26
SCPX Yearly Current Assets VS Current LiabilitesSCPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

SCPX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.42%, which is quite impressive.
The Revenue has grown by 947.53% in the past year. This is a very strong growth!
Measured over the past years, SCPX shows a small growth in Revenue. The Revenue has been growing by 3.85% on average per year.
EPS 1Y (TTM)20.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
Revenue 1Y (TTM)947.53%
Revenue growth 3Y33.35%
Revenue growth 5Y3.85%
Sales Q2Q%356.36%

3.2 Future

SCPX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.10% yearly.
SCPX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 80.70% yearly.
EPS Next Y97.7%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year63.27%
Revenue Next 2Y80.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCPX Yearly Revenue VS EstimatesSCPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
SCPX Yearly EPS VS EstimatesSCPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10K -20K -30K

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SCPX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SCPX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCPX Price Earnings VS Forward Price EarningsSCPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCPX Per share dataSCPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as SCPX's earnings are expected to grow with 41.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.1%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SCPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SCORPIUS HOLDINGS INC

NYSEARCA:SCPX (4/21/2025, 8:04:00 PM)

0.068

-0.06 (-48.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)05-26 2025-05-26
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner Change0%
Market Cap331.16K
Revenue(TTM)9.74M
Net Income(TTM)-36845600
Analysts82.86
Price Target5.1 (7400%)
Short Float %0.13%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-2.97
Fwd EYN/A
FCF(TTM)-4.74
FCFYN/A
OCF(TTM)-4.61
OCFYN/A
SpS2
BVpS5.87
TBVpS5.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.96%
ROE -128.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.54%
FCFM N/A
ROA(3y)-53.06%
ROA(5y)-51.43%
ROE(3y)-77.93%
ROE(5y)-80.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.24%
Cap/Sales 6.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.26
Altman-Z -9.4
F-Score3
WACC4.43%
ROIC/WACCN/A
Cap/Depr(3y)326.96%
Cap/Depr(5y)240.26%
Cap/Sales(3y)144.6%
Cap/Sales(5y)90.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
EPS Next Y97.7%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)947.53%
Revenue growth 3Y33.35%
Revenue growth 5Y3.85%
Sales Q2Q%356.36%
Revenue Next Year63.27%
Revenue Next 2Y80.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.43%
OCF growth 3YN/A
OCF growth 5YN/A

SCORPIUS HOLDINGS INC / SCPX FAQ

What is the fundamental rating for SCPX stock?

ChartMill assigns a fundamental rating of 2 / 10 to SCPX.


What is the valuation status of SCORPIUS HOLDINGS INC (SCPX) stock?

ChartMill assigns a valuation rating of 1 / 10 to SCORPIUS HOLDINGS INC (SCPX). This can be considered as Overvalued.


What is the profitability of SCPX stock?

SCORPIUS HOLDINGS INC (SCPX) has a profitability rating of 1 / 10.


What is the earnings growth outlook for SCORPIUS HOLDINGS INC?

The Earnings per Share (EPS) of SCORPIUS HOLDINGS INC (SCPX) is expected to grow by 97.7% in the next year.